Trials / Withdrawn
WithdrawnNCT00451009
Safety and Efficacy of Freezing and Thawing of Human Eggs in Assisted Reproductive Technology
Safety and Effectiveness of Freeze and Thaw Media Kits for the Manufacturing of Oocytes for Future Use in Assisted Reproductive Technology
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- ViaCell · Industry
- Sex
- Female
- Age
- 21 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the effectiveness of the ViaCell's product media for freezing and thawing human eggs for future use in assisted reproductive technology.
Detailed description
ViaCell's product is an investigational product intended to broaden reproductive options for women through freezing and thawing of human eggs. The egg is a large cell with a high water content, historically making it difficult to freeze. It uses a choline chloride-based media designed to protect the cells from damage during the freezing process with the goal of making it possible to successfully store and thaw eggs for future use. Following informed consent, female subjects will be screened according to the inclusion/exclusion criteria of the protocol and eligible subjects will undergo hormonal stimulation using standard IVF drugs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Viacell's product Media Kits |
Timeline
- Start date
- 2007-03-01
- Completion
- 2009-04-01
- First posted
- 2007-03-22
- Last updated
- 2014-05-29
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00451009. Inclusion in this directory is not an endorsement.